EXOZ · eXoZymes Inc
United States · RS rating 19 · As of 2026-11-03
| Price | 4.75 USD |
|---|---|
| 1-day change | +5.1% |
| RS rating (overall / 1M / 3M / 12M) | 19 / 29 / 41 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 3 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -17.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +71.2% |
| Market cap (USD) | $87.3M |